RE: AZN and GSK15 Apr 2020 02:40
Mon, 6th Apr 2020 07:00 rns
Paris, France anMon, d Camberley, UK - 6 April 2020 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the CNR (Centre National de Référence des Virus des Infections Respiratoires (dont la grippe)) of the Institut Pasteur, an internationally renowned centre for biomedical research with a goal of improving public health in France, has approved its COVID-19 test. The Company's CE-Mark test is available for immediate distribution into the French market.
On 2 April 2020, Novacyt also received approval for its COVID-19 test from the Ministry of Health in Thailand.